Exhaled nitric oxide in guideline-based asthma management

The Lancet

Volumn 372, Issue 9643, 2008, Pages 1015-1017

  Pedersen, Søren ^a   O'Byrne, Paul M ^b  

^a KOLDING HOSPITAL   (Denmark)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID DERIVATIVE; NITRIC OXIDE;

ARTICLE; ASTHMA; DISEASE CONTROL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; EXPIRED AIR; HUMAN; LOW DRUG DOSE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 52049106627     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61420-8     Document Type: Note

References (12)

1. Bateman E.D., Hurd S.S., Barnes P.J., et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31 (2008) 143-178
2. Rabe K.F., Vermeire P.A., Soriano J.B., and Maier W.C. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 16 (2000) 802-807
3. Silkoff P.E., Carlson M., Bourke T., Katial R., Ogren E., and Szefler S.J. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol 114 (2004) 1241-1256
4. Silkoff P.E., McClean P., Spino M., Erlich L., Slutsky A.S., and Zamel N. Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients. Chest 119 (2001) 1322-1328
5. Stirling R.G., Kharitonov S.A., Campbell D., et al., for the Asthma and Allergy Group. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids. Thorax 53 (1998) 1030-1034
6. Szefler S.J., Mitchell H., Sorkness C.A., et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 372 (2008) 1065-1072
7. Smith A.D., Cowan J.O., Brassett K.P., Herbison G.P., and Taylor D.R. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352 (2005) 2163-2173
8. Fritsch M., Uxa S., Horak Jr. F., et al. Exhaled nitric oxide in the management of childhood asthma: a prospective 6-months study. Pediatr Pulmonol 41 (2006) 855-862
9. Pijnenburg M.W., Bakker E.M., Hop W.C., and de Jongste J.C. Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial. Am J Respir Crit Care Med 172 (2005) 831-836
10. Shaw D.E., Berry M.A., Thomas M., et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 176 (2007) 231-237
11. Bateman E.D., Boushey H.A., Bousquet J., et al., for the GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 170 (2004) 836-844
12. Pauwels R.A., Pedersen S., Busse W.W., et al., on behalf of the START Investigators Group. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 361 (2003) 1071-1076